| __timestamp | Catalent, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 334800000 | 381287000 |
| Thursday, January 1, 2015 | 337300000 | 452612000 |
| Friday, January 1, 2016 | 358100000 | 316800000 |
| Sunday, January 1, 2017 | 402600000 | 330100000 |
| Monday, January 1, 2018 | 462600000 | 265800000 |
| Tuesday, January 1, 2019 | 512000000 | 336200000 |
| Wednesday, January 1, 2020 | 577900000 | 423900000 |
| Friday, January 1, 2021 | 687000000 | 467000000 |
| Saturday, January 1, 2022 | 844000000 | 487000000 |
| Sunday, January 1, 2023 | 831000000 | 477100000 |
| Monday, January 1, 2024 | 935000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, understanding financial trends is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of United Therapeutics Corporation and Catalent, Inc. over the past decade. From 2014 to 2023, Catalent's SG&A expenses surged by approximately 179%, reflecting its aggressive expansion and operational scaling. In contrast, United Therapeutics exhibited a steadier growth of around 25% in the same period, indicating a more conservative financial strategy.
Catalent's expenses peaked in 2024, with a notable 11% increase from the previous year, while United Therapeutics' data for 2024 remains unavailable. This trend highlights Catalent's dynamic approach in a competitive market, whereas United Therapeutics maintains a consistent trajectory. These insights offer a window into the strategic priorities of these industry players, providing valuable context for investors and stakeholders.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Apellis Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE
Who Optimizes SG&A Costs Better? Insmed Incorporated or Catalent, Inc.
Bio-Techne Corporation and Catalent, Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for BioMarin Pharmaceutical Inc. and Catalent, Inc.
SG&A Efficiency Analysis: Comparing Catalent, Inc. and Verona Pharma plc
Comparing SG&A Expenses: Catalent, Inc. vs Viking Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Catalent, Inc. and Soleno Therapeutics, Inc.